{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:22:47Z","timestamp":1772223767726,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jpeds.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T17:49:31Z","timestamp":1642614571000},"page":"194-202.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement"],"prefix":"10.1016","volume":"244","author":[{"given":"Ja-Feng","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-1431","authenticated-orcid":false,"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2022.01.007_bib1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2022.01.007_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2022.01.007_bib3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2022.01.007_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2022.01.007_bib5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/pbc.26104","article-title":"Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: in memory of Bob Arceci","volume":"63","author":"Egeler","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2022.01.007_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2022.01.007_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjh.14818","article-title":"Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes","volume":"182","author":"Goyal","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2017.05.059","article-title":"Langerhans cell histiocytosis in children: history, classification, pathobiology, clinical manifestations, and prognosis","volume":"78","author":"Krooks","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaad.2017.05.060","article-title":"Langerhans cell histiocytosis in children: diagnosis, differential diagnosis, treatment, sequelae, and standardized follow-up","volume":"78","author":"Krooks","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2022.01.007_bib11","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2022.01.007_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The role of the thymus in the immune response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jpeds.2022.01.007_bib13","doi-asserted-by":"crossref","first-page":"14419","DOI":"10.1038\/ncomms14419","article-title":"Foxn1-\u03b25t transcriptional axis controls CD8(+) T-cell production in the thymus","volume":"8","author":"Uddin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpeds.2022.01.007_bib14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/pbc.24603","article-title":"Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French National Cohort","volume":"60","author":"Ducassou","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2022.01.007_bib15","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.5858\/2003-127-e294-LCHITT","article-title":"Langerhans cell histiocytosis involving the thymus. A case report and review of the literature","volume":"127","author":"Lee","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jpeds.2022.01.007_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1684\/ejd.2014.2465","article-title":"Langerhans cell histiocytosis involving the skin and the thymus","volume":"25","author":"de Montjoye","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s002470050722","article-title":"The thymus in Langerhans\u2019 cell","volume":"29","author":"Junewick","year":"1999","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fped.2019.00039","article-title":"Ultrasonic manifestations of mesenteric inflammatory myofibroblastic tumors in children","volume":"7","author":"Qian","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpeds.2022.01.007_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","article-title":"How I treat Langerhans cell histiocytosis","volume":"126","author":"Allen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2022.01.007_bib20","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.3324\/haematol.2019.229187","article-title":"Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis","volume":"105","author":"Cui","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jpeds.2022.01.007_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4143\/crt.2020.769","article-title":"Effectiveness and safety of dabrafenib in the treatment of 20 Chinese children with BRAFV600E-mutated Langerhans cell histiocytosis","volume":"53","author":"Yang","year":"2021","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jpeds.2022.01.007_bib22","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"H\u00e9ritier","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","article-title":"Reference values for peripheral blood lymphocyte subsets of healthy children in China","volume":"142","author":"Ding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","article-title":"CD8 T cell responses to infectious pathogens","volume":"21","author":"Wong","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"14","author":"Appay","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jpeds.2022.01.007_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2350\/15-01-1593-OA.1","article-title":"Histologic patterns of thymic involvement in langerhans cell proliferations: a clinicopathologic study and review of the literature","volume":"18","author":"Picarsic","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib28","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.14140","article-title":"Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age","volume":"174","author":"Rigaud","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2022.01.007_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.05.002","article-title":"Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry","volume":"153","author":"Minkov","year":"2008","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:13:11Z","timestamp":1758359591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347622000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":31,"alternative-id":["S0022347622000087"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.01.007","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}